JP7616722B2 - How to raise livestock - Google Patents
How to raise livestock Download PDFInfo
- Publication number
- JP7616722B2 JP7616722B2 JP2023569093A JP2023569093A JP7616722B2 JP 7616722 B2 JP7616722 B2 JP 7616722B2 JP 2023569093 A JP2023569093 A JP 2023569093A JP 2023569093 A JP2023569093 A JP 2023569093A JP 7616722 B2 JP7616722 B2 JP 7616722B2
- Authority
- JP
- Japan
- Prior art keywords
- kinds
- livestock
- vitamin
- composition
- seaweed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 244000144972 livestock Species 0.000 title claims description 37
- 239000000203 mixture Substances 0.000 claims description 43
- 239000003242 anti bacterial agent Substances 0.000 claims description 26
- 229940088710 antibiotic agent Drugs 0.000 claims description 25
- 235000013339 cereals Nutrition 0.000 claims description 21
- 150000004666 short chain fatty acids Chemical class 0.000 claims description 16
- 235000021391 short chain fatty acids Nutrition 0.000 claims description 12
- 241001474374 Blennius Species 0.000 claims description 10
- 239000002075 main ingredient Substances 0.000 claims description 10
- 244000307700 Fragaria vesca Species 0.000 claims description 8
- 240000007594 Oryza sativa Species 0.000 claims description 8
- 235000007164 Oryza sativa Nutrition 0.000 claims description 8
- 235000009566 rice Nutrition 0.000 claims description 8
- 241001672694 Citrus reticulata Species 0.000 claims description 7
- 235000001014 amino acid Nutrition 0.000 claims description 7
- 229940024606 amino acid Drugs 0.000 claims description 7
- 150000001413 amino acids Chemical class 0.000 claims description 7
- 235000020971 citrus fruits Nutrition 0.000 claims description 7
- 210000000936 intestine Anatomy 0.000 claims description 7
- 238000004519 manufacturing process Methods 0.000 claims description 7
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 6
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 6
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 6
- 150000001720 carbohydrates Chemical class 0.000 claims description 6
- 235000014633 carbohydrates Nutrition 0.000 claims description 6
- 235000013399 edible fruits Nutrition 0.000 claims description 6
- 230000004151 fermentation Effects 0.000 claims description 6
- 238000000855 fermentation Methods 0.000 claims description 6
- 241000207199 Citrus Species 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- 235000016413 Actinidia polygama Nutrition 0.000 claims description 4
- 240000006274 Actinidia polygama Species 0.000 claims description 4
- 241000722953 Akebia Species 0.000 claims description 4
- 240000002234 Allium sativum Species 0.000 claims description 4
- 244000144730 Amygdalus persica Species 0.000 claims description 4
- 244000099147 Ananas comosus Species 0.000 claims description 4
- 235000007119 Ananas comosus Nutrition 0.000 claims description 4
- 240000007087 Apium graveolens Species 0.000 claims description 4
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 claims description 4
- 235000010591 Appio Nutrition 0.000 claims description 4
- 240000005528 Arctium lappa Species 0.000 claims description 4
- 235000003130 Arctium lappa Nutrition 0.000 claims description 4
- 235000008078 Arctium minus Nutrition 0.000 claims description 4
- 241000512259 Ascophyllum nodosum Species 0.000 claims description 4
- 241001107116 Castanospermum australe Species 0.000 claims description 4
- 235000008733 Citrus aurantifolia Nutrition 0.000 claims description 4
- 241000951471 Citrus junos Species 0.000 claims description 4
- 235000005979 Citrus limon Nutrition 0.000 claims description 4
- 244000175448 Citrus madurensis Species 0.000 claims description 4
- 244000131522 Citrus pyriformis Species 0.000 claims description 4
- 235000005976 Citrus sinensis Nutrition 0.000 claims description 4
- 240000002319 Citrus sinensis Species 0.000 claims description 4
- 240000000560 Citrus x paradisi Species 0.000 claims description 4
- 240000008067 Cucumis sativus Species 0.000 claims description 4
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 claims description 4
- 235000002767 Daucus carota Nutrition 0.000 claims description 4
- 244000000626 Daucus carota Species 0.000 claims description 4
- 235000011511 Diospyros Nutrition 0.000 claims description 4
- 244000236655 Diospyros kaki Species 0.000 claims description 4
- 244000239348 Echinochloa crus galli var. praticola Species 0.000 claims description 4
- 241000196324 Embryophyta Species 0.000 claims description 4
- 235000009008 Eriobotrya japonica Nutrition 0.000 claims description 4
- 244000061508 Eriobotrya japonica Species 0.000 claims description 4
- 235000017317 Fortunella Nutrition 0.000 claims description 4
- 235000016970 Fragaria moschata Nutrition 0.000 claims description 4
- 235000016623 Fragaria vesca Nutrition 0.000 claims description 4
- 235000014828 Fragaria vesca ssp. americana Nutrition 0.000 claims description 4
- 235000012660 Fragaria virginiana Nutrition 0.000 claims description 4
- 235000011363 Fragaria x ananassa Nutrition 0.000 claims description 4
- 229930091371 Fructose Natural products 0.000 claims description 4
- 239000005715 Fructose Substances 0.000 claims description 4
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 4
- 235000010469 Glycine max Nutrition 0.000 claims description 4
- 244000068988 Glycine max Species 0.000 claims description 4
- 240000005979 Hordeum vulgare Species 0.000 claims description 4
- 235000007340 Hordeum vulgare Nutrition 0.000 claims description 4
- 241000758791 Juglandaceae Species 0.000 claims description 4
- 241000234435 Lilium Species 0.000 claims description 4
- 241000220225 Malus Species 0.000 claims description 4
- 235000011430 Malus pumila Nutrition 0.000 claims description 4
- 235000015103 Malus silvestris Nutrition 0.000 claims description 4
- 235000008708 Morus alba Nutrition 0.000 claims description 4
- 240000000249 Morus alba Species 0.000 claims description 4
- 240000005561 Musa balbisiana Species 0.000 claims description 4
- 235000018290 Musa x paradisiaca Nutrition 0.000 claims description 4
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims description 4
- 240000002853 Nelumbo nucifera Species 0.000 claims description 4
- 244000124853 Perilla frutescens Species 0.000 claims description 4
- 235000006089 Phaseolus angularis Nutrition 0.000 claims description 4
- 241000206607 Porphyra umbilicalis Species 0.000 claims description 4
- 235000006040 Prunus persica var persica Nutrition 0.000 claims description 4
- 244000184734 Pyrus japonica Species 0.000 claims description 4
- 240000007651 Rubus glaucus Species 0.000 claims description 4
- 235000011034 Rubus glaucus Nutrition 0.000 claims description 4
- 235000009122 Rubus idaeus Nutrition 0.000 claims description 4
- 235000003434 Sesamum indicum Nutrition 0.000 claims description 4
- 244000040738 Sesamum orientale Species 0.000 claims description 4
- 240000005498 Setaria italica Species 0.000 claims description 4
- 244000062793 Sorghum vulgare Species 0.000 claims description 4
- 229920002472 Starch Polymers 0.000 claims description 4
- 235000011941 Tilia x europaea Nutrition 0.000 claims description 4
- 235000021307 Triticum Nutrition 0.000 claims description 4
- 244000098338 Triticum aestivum Species 0.000 claims description 4
- 241001261506 Undaria pinnatifida Species 0.000 claims description 4
- 240000000851 Vaccinium corymbosum Species 0.000 claims description 4
- 235000003095 Vaccinium corymbosum Nutrition 0.000 claims description 4
- 235000017537 Vaccinium myrtillus Nutrition 0.000 claims description 4
- 235000010711 Vigna angularis Nutrition 0.000 claims description 4
- 240000007098 Vigna angularis Species 0.000 claims description 4
- 235000009754 Vitis X bourquina Nutrition 0.000 claims description 4
- 235000012333 Vitis X labruscana Nutrition 0.000 claims description 4
- 240000006365 Vitis vinifera Species 0.000 claims description 4
- 235000014787 Vitis vinifera Nutrition 0.000 claims description 4
- 235000017190 Vitis vinifera subsp sylvestris Nutrition 0.000 claims description 4
- 244000237969 Vitis vulpina Species 0.000 claims description 4
- 235000017242 Vitis vulpina Nutrition 0.000 claims description 4
- 240000008042 Zea mays Species 0.000 claims description 4
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 4
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 4
- 235000006886 Zingiber officinale Nutrition 0.000 claims description 4
- 244000273928 Zingiber officinale Species 0.000 claims description 4
- 235000021028 berry Nutrition 0.000 claims description 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 4
- 235000021279 black bean Nutrition 0.000 claims description 4
- 235000007215 black sesame Nutrition 0.000 claims description 4
- 235000021014 blueberries Nutrition 0.000 claims description 4
- 235000021329 brown rice Nutrition 0.000 claims description 4
- 235000005822 corn Nutrition 0.000 claims description 4
- 235000004611 garlic Nutrition 0.000 claims description 4
- 235000008397 ginger Nutrition 0.000 claims description 4
- 239000008103 glucose Substances 0.000 claims description 4
- 235000012907 honey Nutrition 0.000 claims description 4
- 239000004571 lime Substances 0.000 claims description 4
- 235000019713 millet Nutrition 0.000 claims description 4
- 235000002252 panizo Nutrition 0.000 claims description 4
- 235000019698 starch Nutrition 0.000 claims description 4
- 239000008107 starch Substances 0.000 claims description 4
- 235000020234 walnut Nutrition 0.000 claims description 4
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 3
- 239000004475 Arginine Substances 0.000 claims description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 3
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims description 3
- 239000004471 Glycine Substances 0.000 claims description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 3
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 3
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 3
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 claims description 3
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 3
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 3
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims description 3
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims description 3
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims description 3
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 3
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 3
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 3
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 3
- 239000004472 Lysine Substances 0.000 claims description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 3
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 3
- 241000207960 Pedaliaceae Species 0.000 claims description 3
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims description 3
- 244000046052 Phaseolus vulgaris Species 0.000 claims description 3
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 3
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims description 3
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 3
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 3
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims description 3
- 239000004473 Threonine Substances 0.000 claims description 3
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims description 3
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims description 3
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 3
- 229930003427 Vitamin E Natural products 0.000 claims description 3
- 235000004279 alanine Nutrition 0.000 claims description 3
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 claims description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 3
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 3
- 235000003704 aspartic acid Nutrition 0.000 claims description 3
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims description 3
- 239000011648 beta-carotene Substances 0.000 claims description 3
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 claims description 3
- 235000013734 beta-carotene Nutrition 0.000 claims description 3
- 229960002747 betacarotene Drugs 0.000 claims description 3
- 239000011575 calcium Substances 0.000 claims description 3
- 229910052791 calcium Inorganic materials 0.000 claims description 3
- 229910052802 copper Inorganic materials 0.000 claims description 3
- 239000010949 copper Substances 0.000 claims description 3
- 229960003067 cystine Drugs 0.000 claims description 3
- 239000000835 fiber Substances 0.000 claims description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 3
- 235000013922 glutamic acid Nutrition 0.000 claims description 3
- 239000004220 glutamic acid Substances 0.000 claims description 3
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims description 3
- 229910052742 iron Inorganic materials 0.000 claims description 3
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims description 3
- 229960000310 isoleucine Drugs 0.000 claims description 3
- 150000002632 lipids Chemical class 0.000 claims description 3
- 239000011777 magnesium Substances 0.000 claims description 3
- 229910052749 magnesium Inorganic materials 0.000 claims description 3
- 229930182817 methionine Natural products 0.000 claims description 3
- 229960003512 nicotinic acid Drugs 0.000 claims description 3
- 235000001968 nicotinic acid Nutrition 0.000 claims description 3
- 239000011664 nicotinic acid Substances 0.000 claims description 3
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims description 3
- 239000011574 phosphorus Substances 0.000 claims description 3
- 229910052698 phosphorus Inorganic materials 0.000 claims description 3
- 239000011591 potassium Substances 0.000 claims description 3
- 229910052700 potassium Inorganic materials 0.000 claims description 3
- 235000018102 proteins Nutrition 0.000 claims description 3
- 108090000623 proteins and genes Proteins 0.000 claims description 3
- 102000004169 proteins and genes Human genes 0.000 claims description 3
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- 239000011734 sodium Substances 0.000 claims description 3
- 229910052708 sodium Inorganic materials 0.000 claims description 3
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 3
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims description 3
- 239000004474 valine Substances 0.000 claims description 3
- 235000019155 vitamin A Nutrition 0.000 claims description 3
- 239000011719 vitamin A Substances 0.000 claims description 3
- 239000011691 vitamin B1 Substances 0.000 claims description 3
- 239000011716 vitamin B2 Substances 0.000 claims description 3
- 239000011726 vitamin B6 Substances 0.000 claims description 3
- 235000019165 vitamin E Nutrition 0.000 claims description 3
- 239000011709 vitamin E Substances 0.000 claims description 3
- 229940046009 vitamin E Drugs 0.000 claims description 3
- 229940045997 vitamin a Drugs 0.000 claims description 3
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 claims description 3
- 235000013372 meat Nutrition 0.000 claims description 2
- 238000012360 testing method Methods 0.000 description 19
- 241000282887 Suidae Species 0.000 description 17
- 230000002550 fecal effect Effects 0.000 description 14
- 235000013305 food Nutrition 0.000 description 12
- 206010012735 Diarrhoea Diseases 0.000 description 9
- 239000008280 blood Substances 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 9
- 230000000968 intestinal effect Effects 0.000 description 9
- 241000894006 Bacteria Species 0.000 description 8
- 210000001035 gastrointestinal tract Anatomy 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 238000009395 breeding Methods 0.000 description 5
- 241000282898 Sus scrofa Species 0.000 description 4
- 230000003115 biocidal effect Effects 0.000 description 4
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 239000004190 Avilamycin Substances 0.000 description 3
- 229930192734 Avilamycin Natural products 0.000 description 3
- XIRGHRXBGGPPKY-OTPQUNEMSA-N [(2r,3s,4r,6s)-6-[(2'r,3's,3ar,4r,4'r,6s,7ar)-6-[(2s,3r,4r,5s,6r)-2-[(2r,3s,4s,5s,6s)-6-[(2r,3as,3'ar,6'r,7r,7's,7ar,7'ar)-7'-acetyl-7'-hydroxy-6'-methyl-7-(2-methylpropanoyloxy)spiro[4,6,7,7a-tetrahydro-3ah-[1,3]dioxolo[4,5-c]pyran-2,4'-6,7a-dihydro-3ah- Chemical compound O([C@H]1[C@H](O)C[C@@H](O[C@@H]1C)O[C@H]1[C@H](O)CC2(O[C@]3(C)C[C@@H](O[C@H](C)[C@H]3O2)O[C@H]2[C@@H](OC)[C@@H](C)O[C@H]([C@@H]2O)O[C@H]2[C@H](O)[C@H](OC)[C@H](OC3[C@@H]([C@@H]4O[C@]5(O[C@H]4CO3)[C@@H]3OCO[C@H]3[C@@](O)([C@@H](C)O5)C(C)=O)OC(=O)C(C)C)O[C@@H]2COC)O[C@@H]1C)C(=O)C1=C(C)C(Cl)=C(O)C(Cl)=C1OC XIRGHRXBGGPPKY-OTPQUNEMSA-N 0.000 description 3
- 229960005185 avilamycin Drugs 0.000 description 3
- 235000019379 avilamycin Nutrition 0.000 description 3
- 230000001488 breeding effect Effects 0.000 description 3
- 210000004347 intestinal mucosa Anatomy 0.000 description 3
- 230000035800 maturation Effects 0.000 description 3
- 235000013406 prebiotics Nutrition 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 239000003053 toxin Substances 0.000 description 3
- 231100000765 toxin Toxicity 0.000 description 3
- 108700012359 toxins Proteins 0.000 description 3
- 235000013311 vegetables Nutrition 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 208000035473 Communicable disease Diseases 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000007358 intestinal barrier function Effects 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 235000019260 propionic acid Nutrition 0.000 description 2
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 2
- 238000003307 slaughter Methods 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 230000004584 weight gain Effects 0.000 description 2
- 235000019786 weight gain Nutrition 0.000 description 2
- GRHBODILPPXVKN-UHFFFAOYSA-N 2-[2-(3-butoxyphenyl)ethylamino]-n,n-dimethylacetamide Chemical compound CCCCOC1=CC=CC(CCNCC(=O)N(C)C)=C1 GRHBODILPPXVKN-UHFFFAOYSA-N 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 241000273649 Citrus hassaku Species 0.000 description 1
- 241000555678 Citrus unshiu Species 0.000 description 1
- 108010078777 Colistin Proteins 0.000 description 1
- 101710173228 Glutathione hydrolase proenzyme Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- MVTQIFVKRXBCHS-SMMNFGSLSA-N N-[(3S,6S,12R,15S,16R,19S,22S)-3-benzyl-12-ethyl-4,16-dimethyl-2,5,11,14,18,21,24-heptaoxo-19-phenyl-17-oxa-1,4,10,13,20-pentazatricyclo[20.4.0.06,10]hexacosan-15-yl]-3-hydroxypyridine-2-carboxamide (10R,11R,12E,17E,19E,21S)-21-hydroxy-11,19-dimethyl-10-propan-2-yl-9,26-dioxa-3,15,28-triazatricyclo[23.2.1.03,7]octacosa-1(27),6,12,17,19,25(28)-hexaene-2,8,14,23-tetrone Chemical compound CC(C)[C@H]1OC(=O)C2=CCCN2C(=O)c2coc(CC(=O)C[C@H](O)\C=C(/C)\C=C\CNC(=O)\C=C\[C@H]1C)n2.CC[C@H]1NC(=O)[C@@H](NC(=O)c2ncccc2O)[C@@H](C)OC(=O)[C@@H](NC(=O)[C@@H]2CC(=O)CCN2C(=O)[C@H](Cc2ccccc2)N(C)C(=O)[C@@H]2CCCN2C1=O)c1ccccc1 MVTQIFVKRXBCHS-SMMNFGSLSA-N 0.000 description 1
- 239000004188 Virginiamycin Substances 0.000 description 1
- 108010080702 Virginiamycin Proteins 0.000 description 1
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000003674 animal food additive Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229960003346 colistin Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- NJCUSQKMYNTYOW-MWUYRYRWSA-N enramicina Chemical compound O.N1C(=O)NC(=O)C(C=2C=C(Cl)C(O)=C(Cl)C=2)NC(=O)C(CO)NC(=O)C(C=2C=CC(O)=CC=2)NC(=O)C(CC2N=C(N)NC2)NC(=O)C(CCCNC(N)=O)NC(=O)C(C(C)O)NC(=O)C(C=2C=CC(O)=CC=2)NC(=O)C(C=2C=CC(O)=CC=2)NC(=O)C(C(C)O)NC(=O)N(CCCCN)C(=O)C(C=2C=CC(O)=CC=2)NC(=O)C(NC(=O)C(CC(O)=O)NC(=O)/C=C/C=C/CCCCC(C)CC)C(C)OC(=O)C(C=2C=CC(O)=CC=2)NC(=O)C(C)NC(=O)C1CC1CNC(N)=N1 NJCUSQKMYNTYOW-MWUYRYRWSA-N 0.000 description 1
- 229950003984 enramycin Drugs 0.000 description 1
- 108700041171 enramycin Proteins 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 235000021050 feed intake Nutrition 0.000 description 1
- WGXUDTHMEITUBO-YFKPBYRVSA-N glutaurine Chemical compound OC(=O)[C@@H](N)CCC(=O)NCCS(O)(=O)=O WGXUDTHMEITUBO-YFKPBYRVSA-N 0.000 description 1
- -1 heat Substances 0.000 description 1
- 210000002490 intestinal epithelial cell Anatomy 0.000 description 1
- 230000008944 intestinal immunity Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- JORAUNFTUVJTNG-BSTBCYLQSA-N n-[(2s)-4-amino-1-[[(2s,3r)-1-[[(2s)-4-amino-1-oxo-1-[[(3s,6s,9s,12s,15r,18s,21s)-6,9,18-tris(2-aminoethyl)-3-[(1r)-1-hydroxyethyl]-12,15-bis(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-h Chemical compound CC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@H]([C@@H](C)O)CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O.CCC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@H]([C@@H](C)O)CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O JORAUNFTUVJTNG-BSTBCYLQSA-N 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- XDJYMJULXQKGMM-UHFFFAOYSA-N polymyxin E1 Natural products CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(C(C)O)NC(=O)C(CCN)NC(=O)C(CCN)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CCN)NC1=O XDJYMJULXQKGMM-UHFFFAOYSA-N 0.000 description 1
- KNIWPHSUTGNZST-UHFFFAOYSA-N polymyxin E2 Natural products CC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(C(C)O)NC(=O)C(CCN)NC(=O)C(CCN)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CCN)NC1=O KNIWPHSUTGNZST-UHFFFAOYSA-N 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 229960003842 virginiamycin Drugs 0.000 description 1
- 235000019373 virginiamycin Nutrition 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/12—Animal feeding-stuffs obtained by microbiological or biochemical processes by fermentation of natural products, e.g. of vegetable material, animal waste material or biomass
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P60/00—Technologies relating to agriculture, livestock or agroalimentary industries
- Y02P60/80—Food processing, e.g. use of renewable energies or variable speed drives in handling, conveying or stacking
- Y02P60/87—Re-use of by-products of food processing for fodder production
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Physiology (AREA)
- Birds (AREA)
- Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Sustainable Development (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Fodder In General (AREA)
- Feed For Specific Animals (AREA)
Description
特許法第30条第2項適用 1.集会 開催日 2021年11月4日 集会名 第115回日本養豚学会大会(日本養豚学会) 開催場所 リモート開催 2.刊行物 発行日 2021年11月4日 刊行物 第115回日本養豚学会大会講演要旨、第6頁、日本養豚学会
本発明は、家畜飼料用の発酵組成物、及び、当該発酵組成物を用いた家畜の飼育方法に関する。The present invention relates to a fermented composition for livestock feed and a method for raising livestock using the fermented composition.
食用豚などの家畜の飼育には、飼料の給餌の他に成長目的のためのアビラマイシン、エンラマイシン、バージニアマイシン、コリスチンなどの抗生物質を与えていることがある。
成長目的での抗生物質の使用は、飼料に混ぜて継続的に使用されるものである。投与量は、一般的には治療目的の抗生物質の使用量に対して低用量で用いられている。
投与量など使用基準は、抗生物質ごとに定められている。
When raising livestock such as pigs for food, in addition to feeding them feed, they may be given antibiotics such as avilamycin, enramycin, virginiamycin, and colistin for growth purposes.
Antibiotics for growth purposes are administered continuously via feed, and the dosage is generally lower than that of antibiotics used for therapeutic purposes.
Usage standards, such as dosage, are set for each antibiotic.
家畜の飼育において、成長目的で抗生物質を家畜に与える理由は、腸内の有害菌が産生する毒素・腐敗物の発生を抑えることで絨毛・陰窩の損傷を防ぐことにより、家畜の下痢を抑制して、健全な家畜の成長を図るものである。 In livestock breeding, the reason antibiotics are given to livestock for growth purposes is to suppress the production of toxins and putrefactive matter produced by harmful bacteria in the intestines, thereby preventing damage to the villi and crypts, thereby suppressing diarrhea in livestock and promoting healthy growth.
しかし、この抗生物質に対する耐性菌が出現することで、抗生物質の効果が弱くなり、毒素・腐敗物の発生を防ぐことができず、家畜の下痢を発生させてしまう。また、昨今の自然食ブームのなかでも、抗生物質を与えた家畜など消費者の購入を躊躇させるなどの影響もある。 However, the emergence of antibiotic-resistant bacteria weakens the effectiveness of antibiotics, making it impossible to prevent the production of toxins and putrefaction, which can lead to diarrhea in livestock. Furthermore, even amid the recent boom in natural foods, this has the effect of making consumers hesitant to purchase livestock that have been fed antibiotics.
本発明者らは、果物、穀類、海藻類、野菜から特定の複数種類の原材料を長期間の発酵熟成させた発酵組成物の利用や効果について鋭意研究している。当該発酵組成物が動物の腸内での短鎖脂肪酸の産生が増加することを見出し、家畜に与える抗生物質を代替できないか否かの仮説を立てて、試行錯誤や各種実験を経て、本発明に至ったものである。The inventors have been conducting extensive research into the use and effects of fermented compositions made by fermenting and maturing specific types of raw materials, including fruits, grains, seaweed, and vegetables, for extended periods of time. They discovered that the fermented composition increases the production of short-chain fatty acids in the intestines of animals, and hypothesized whether it could be used as an alternative to antibiotics given to livestock. Through trial and error and various experiments, they arrived at the present invention.
本発明がその技術的課題を解決するために用いる技術的手段としては、次のようなものである。The technical means used by the present invention to solve the technical problem are as follows:
すなわち、本発明は、果実類に属するリンゴ、柿、バナナ、パインアップル、アケビ、マタタビ、イチジク、野いちご、いちご、山ぶどう、ぶどう、山挑、もも、梅、ブルーベリー、ラズベリーから選ばれる1種または2種以上のものと、かんきつ類に属するネーブル、ハッサク、温州みかん、夏みかん、オレンジ、伊予柑、きんかん、ゆず、カボス、ザボン、ポンカン、レモン、ライムから選ばれる1種または2種以上のものと、根菜類に属するゴボウ、ニンジン、ニンニク、レンコン、ゆり根から選ばれる1種または2種以上のものと、穀類に属する玄米、もち米、白米、きび、とうもろこし、小麦、大麦、あわ、ひえから選ばれる1種または2種以上のものと、豆・ゴマ類に属する大豆、黒豆、黒ゴマ、白ゴマ、あずき、くるみから選ばれる1種または2種以上のものと、海草類に属するコンブ、ワカメ、ヒジキ、あおのり、かわのりから選ばれる1種または2種以上のものと、糖類に属する黒糖、果糖、ぶどう糖から選ばれる1種または2種以上のものと、はちみつ、澱粉、きゅうり、しそ、セロリから選ばれる1種または2種以上のものとを、発酵、熟成させることで得られ、次の成分及びアミノ酸組成からなる、
主成分について、100g当たり、下記を含む、
水分:5.0g~50.0g、
タンパク質:0.5g~10.0g、
脂質:0.05g~10.00g、
炭水化物(糖質):30.0g~75.0g、
炭水化物(繊維):0.1g~5.0g、
灰分:0.5g~5.0g、
β-カロチン:10μg~150μg、
ビタミンA効力:10IU~100IU、
ビタミンB1:0.01mg~0.50mg、
ビタミンB2:0.01mg~0.50mg、
ビタミンB6:0.01mg~0.50mg、
ビタミンE:10.0mg以下、
ナイアシン:0.1mg~6.0mg、
カルシウム:50mg~900mg、
リン:200mg以下、
鉄:1.0mg~5.0mg、
ナトリウム:20mg~300mg、
カリウム:300mg~1000mg、
マグネシウム:40mg~200mg、
食塩相当量:0.05g~1.00g、
銅:7.0ppm以下。
アミノ酸組成について、100g中、
イソロイシン:30~200mg、
ロイシン:50~400mg、
リジン:20~200mg、
メチオニン:10~150mg、
シスチン:10~100mg、
フェニルアラニン:30~250mg、
チロシン:20~200mg、
スレオニン:40~200mg、
トリプトファン:1~100mg、
バリン:30~300mg、
ヒスチジン:10~200mg、
アルギニン:40~400mg、
アラニン:50~300mg、
アスパラキン酸:100~600mg、
グルタミン酸:100~1200mg、
グリシン:30~300mg、
プロリン:40~400mg、
セリン:30~300mg。
発酵組成物を主原料とする飼料用(家畜用)の植物発酵組成材を提供するものである。この発酵組成物は、家畜の腸内で特定の短鎖脂肪酸を増加させる特徴のあるものとしても良い。
That is, the present invention relates to one or more kinds of fruit selected from apple, persimmon, banana, pineapple, Akebia japonica, silver vine, fig, wild strawberry, strawberry, wild grape, grape, wild berry, peach, plum, blueberry, and raspberry, which belong to fruits, one or more kinds of citrus fruit selected from navel orange, hassaku orange, Unshu mandarin orange, summer mandarin orange, orange, Iyokan orange, kumquat, yuzu, kabosu, pomelo, ponkan, lemon, and lime, which belong to root vegetables, one or more kinds of burdock, carrot, garlic, lotus root, and lily root, which belong to grains, and brown rice, The product is obtained by fermenting and maturing one or more kinds of food selected from glutinous rice, white rice, millet, corn, wheat, barley, foxtail millet, and barnyard millet, one or more kinds of food selected from soybeans, black beans, black sesame seeds, white sesame seeds, adzuki beans, and walnuts, which belong to the beans and sesame family, one or more kinds of food selected from kelp, wakame, hijiki, green laver, and seaweed, which belong to the seaweed family, one or more kinds of food selected from brown sugar, fructose, and glucose, which belong to the sugar family, and one or more kinds of food selected from honey, starch, cucumber, shiso, and celery, and has the following components and amino acid composition:
The main ingredients per 100g include:
Moisture: 5.0g to 50.0g,
Protein: 0.5g-10.0g,
Lipids: 0.05g to 10.00g,
Carbohydrates (sugar): 30.0g to 75.0g,
Carbohydrates (fiber): 0.1g-5.0g,
Ash content: 0.5g to 5.0g,
β-carotene: 10 μg to 150 μg,
Vitamin A potency: 10 IU to 100 IU,
Vitamin B1 : 0.01 mg to 0.50 mg,
Vitamin B2 : 0.01mg to 0.50mg,
Vitamin B6 : 0.01mg to 0.50mg,
Vitamin E: 10.0 mg or less,
Niacin: 0.1 mg to 6.0 mg,
Calcium: 50mg to 900mg,
Phosphorus: 200 mg or less,
Iron: 1.0 mg to 5.0 mg,
Sodium: 20mg to 300mg,
Potassium: 300mg to 1000mg,
Magnesium: 40mg to 200mg,
Salt equivalent: 0.05g to 1.00g,
Copper: 7.0 ppm or less.
Amino acid composition per 100g:
Isoleucine: 30-200 mg,
Leucine: 50-400 mg,
Lysine: 20-200 mg,
Methionine: 10-150 mg,
Cystine: 10-100 mg,
Phenylalanine: 30-250 mg,
Tyrosine: 20-200 mg,
Threonine: 40-200 mg,
Tryptophan: 1-100 mg,
Valine: 30-300 mg,
Histidine: 10-200 mg,
Arginine: 40-400 mg,
Alanine: 50-300 mg,
Aspartic acid: 100-600 mg,
Glutamic acid: 100-1200 mg,
Glycine: 30-300 mg,
Proline: 40-400 mg,
Serine: 30-300 mg.
The present invention provides a plant fermented composition for use as feed (for livestock), the fermented composition being the main ingredient. The fermented composition may be characterized by increasing specific short-chain fatty acids in the intestines of livestock.
前記発酵組成物の原材料に、桑、生姜、枇杷のうち1又は2以上の種類を加えた発酵、熟成させることで得られ、前記の成分及びアミノ酸組成からなる発酵組成物を主原料とする飼料用(家畜用)の植物発酵組成材を提供するものである。 The present invention provides a plant fermented composition for feed (for livestock) that is obtained by adding one or more of mulberry, ginger, and loquat to the raw materials for the fermented composition, followed by fermentation and maturation, and that uses as its main ingredient a fermented composition that is composed of the above-mentioned components and amino acid composition.
前記発酵組成物を主原料とする家畜の下痢を抑制させることを特徴とする請求項1又は2に記載のプレバイオテックス食品を含む抗生物質代替材を提供するものである。
The present invention provides an alternative to antibiotics, comprising the prebiotic food according to
果実類に属するリンゴ、柿、バナナ、パインアップル、アケビ、マタタビ、イチジク、野いちご、いちご、山ぶどう、ぶどう、山挑、もも、梅、ブルーベリー、ラズベリー、枇杷から選ばれる1種または2種以上のものと、かんきつ類に属するネーブル、ハッサク、温州みかん、夏みかん、オレンジ、伊予柑、きんかん、ゆず、カボス、ザボン、ポンカン、レモン、ライムから選ばれる1種または2種以上のものと、根菜類に属するゴボウ、ニンジン、ニンニク、レンコン、ゆり根から選ばれる1種または2種以上のものと、穀類に属する玄米、もち米、白米、きび、とうもろこし、小麦、大麦、あわ、ひえから選ばれる1種または2種以上のものと、豆・ゴマ類に属する大豆、黒豆、黒ゴマ、白ゴマ、あずき、くるみから選ばれる1種または2種以上のものと、海草類に属するコンブ、ワカメ、ヒジキ、あおのり、かわのりから選ばれる1種または2種以上のものと、糖類に属する黒糖、果糖、ぶどう糖から選ばれる1種または2種以上のものと、はちみつ、澱粉、きゅうり、しそ、セロリ、桑、生姜から選ばれる1種または2種以上のものとを、発酵、熟成させることで得られ、次の成分及びアミノ酸組成からなる、
主成分について、100g当たり、下記を含む、
水分:5.0g~50.0g、
タンパク質:0.5g~10.0g、
脂質:0.05g~10.00g、
炭水化物(糖質):30.0g~75.0g、
炭水化物(繊維):0.1g~5.0g、
灰分:0.5g~5.0g、
β-カロチン:10μg~150μg、
ビタミンA効力:10IU~100IU、
ビタミンB1:0.01mg~0.50mg、
ビタミンB2:0.01mg~0.50mg、
ビタミンB6:0.01mg~0.50mg、
ビタミンE:10.0mg以下、
ナイアシン:0.1mg~6.0mg、
カルシウム:50mg~900mg、
リン:200mg以下、
鉄:1.0mg~5.0mg、
ナトリウム:20mg~300mg、
カリウム:300mg~1000mg、
マグネシウム:40mg~200mg、
食塩相当量:0.05g~1.00g、
銅:7.0ppm以下。
アミノ酸組成について、100g中、
イソロイシン:30~200mg、
ロイシン:50~400mg、
リジン:20~200mg、
メチオニン:10~150mg、
シスチン:10~100mg、
フェニルアラニン:30~250mg、
チロシン:20~200mg、
スレオニン:40~200mg、
トリプトファン:1~100mg、
バリン:30~300mg、
ヒスチジン:10~200mg、
アルギニン:40~400mg、
アラニン:50~300mg、
アスパラキン酸:100~600mg、
グルタミン酸:100~1200mg、
グリシン:30~300mg、
プロリン:40~400mg、
セリン:30~300mg。
発酵組成物を主原料とする飼料用のプレバイオテックス添加物を家畜に給餌することによる家畜の飼育方法としても良い。この発酵組成物は、家畜の腸内で特定の短鎖脂肪酸を増加させる特徴のあるものとしても良い。
One or more kinds selected from apple, persimmon, banana, pineapple, Akebia japonica, silver vine, fig, wild strawberry, strawberry, wild grape, grape, wild berry, peach, plum, blueberry, raspberry, loquat belonging to the fruit category; one or more kinds selected from navel orange, hassaku citrus, Unshu mandarin orange, summer mandarin orange, orange, Iyokan, kumquat, yuzu, kabosu, pomelo, ponkan, lemon, lime belonging to the citrus category; one or more kinds selected from burdock, carrot, garlic, lotus root, lily root belonging to the root category; brown rice, glutinous rice, polished rice belonging to the grain category, The present invention is obtained by fermenting and maturing one or more kinds of grains selected from millet, corn, wheat, barley, foxtail millet, and barnyard millet, one or more kinds of grains selected from soybeans, black beans, black sesame seeds, white sesame seeds, adzuki beans, and walnuts, which belong to the beans and sesame family, one or more kinds of grains selected from kelp, wakame, hijiki, green laver, and seaweed, which belong to the seaweed family, one or more kinds of grains selected from brown sugar, fructose, and glucose, which belong to the sugar family, and one or more kinds of grains selected from honey, starch, cucumber, shiso, celery, mulberry, and ginger, and has the following components and amino acid composition:
The main ingredients per 100g include:
Moisture: 5.0g to 50.0g,
Protein: 0.5g-10.0g,
Lipids: 0.05g to 10.00g,
Carbohydrates (sugar): 30.0g to 75.0g,
Carbohydrates (fiber): 0.1g-5.0g,
Ash content: 0.5g to 5.0g,
β-carotene: 10 μg to 150 μg,
Vitamin A potency: 10 IU to 100 IU,
Vitamin B1 : 0.01 mg to 0.50 mg,
Vitamin B2 : 0.01mg to 0.50mg,
Vitamin B6 : 0.01mg to 0.50mg,
Vitamin E: 10.0 mg or less,
Niacin: 0.1 mg to 6.0 mg,
Calcium: 50mg to 900mg,
Phosphorus: 200 mg or less,
Iron: 1.0 mg to 5.0 mg,
Sodium: 20mg to 300mg,
Potassium: 300mg to 1000mg,
Magnesium: 40mg to 200mg,
Salt equivalent: 0.05g to 1.00g,
Copper: 7.0 ppm or less.
Amino acid composition per 100g:
Isoleucine: 30-200 mg,
Leucine: 50-400 mg,
Lysine: 20-200 mg,
Methionine: 10-150 mg,
Cystine: 10-100 mg,
Phenylalanine: 30-250 mg,
Tyrosine: 20-200 mg,
Threonine: 40-200 mg,
Tryptophan: 1-100 mg,
Valine: 30-300 mg,
Histidine: 10-200 mg,
Arginine: 40-400 mg,
Alanine: 50-300 mg,
Aspartic acid: 100-600 mg,
Glutamic acid: 100-1200 mg,
Glycine: 30-300 mg,
Proline: 40-400 mg,
Serine: 30-300 mg.
The present invention may also be used as a livestock breeding method by feeding livestock a prebiotic feed additive containing the fermented composition as a main ingredient, the fermented composition being characterized in that it increases specific short-chain fatty acids in the intestines of the livestock.
前記発酵組成物を主原料とする飼料用のプレバイオテックス添加物を家畜に給餌することによる抗生物質の非投与若しくは使用量を削減するとする家畜の飼育方法としても良い。この発酵組成物は、家畜の腸内で特定の短鎖脂肪酸を増加させる特徴のあるものとしても良い。The present invention may also be used as a livestock breeding method in which a prebiotic additive for feed containing the fermented composition as a main ingredient is fed to livestock, thereby eliminating the need for or reducing the amount of antibiotics used. The fermented composition may be characterized by increasing specific short-chain fatty acids in the intestines of livestock.
本件発酵組成物を健常な家畜に与えることによって、抗生物質を非投与とした家畜の飼育条件下において、抗生物質の投与群と同程度の家畜の生育状況とすることができた。By feeding this fermented composition to healthy livestock, it was possible to achieve growth conditions for livestock that were not administered antibiotics, similar to those of a group administered antibiotics.
具体的には、本件発酵組成物の投与群は、抗生物質の投与群と比較して同程度の家畜の増体を維持して、血液、腸管の長さや重量、絨毛組織に有意な変化と異常所見を与えず、下痢症状(糞便スコア)も同程度であった。Specifically, the group administered the fermented composition maintained the same level of weight gain in livestock compared to the group administered antibiotics, and showed no significant changes or abnormal findings in blood, intestinal length or weight, or villus tissue, and also had the same level of diarrhea symptoms (fecal score).
以下、添付図面及び実施例を組み合わせて本発明を更に説明する。The present invention will now be further described in conjunction with the accompanying drawings and examples.
本発明者は、本発酵組成物に着目をして、抗生物質を非投与とした家畜条件下での家畜(特に、食用豚)の育成において、その生育に影響を与えるか否かを実験した。The inventors focused on this fermented composition and conducted experiments to determine whether it had an effect on the growth of livestock (particularly pigs for food) raised under livestock conditions without the administration of antibiotics.
本発酵組成物(FBP)は、果実類に属するリンゴ、柿、バナナ、パインアップル、アケビ、マタタビ、イチジク、野いちご、いちご、山ぶどう、ぶどう、山挑、もも、梅、ブルーベリー、ラズベリー、枇杷から選ばれる1種または2種以上のものと、かんきつ類に属するネーブル、ハッサク、温州みかん、夏みかん、オレンジ、伊予柑、きんかん、ゆず、カボス、ザボン、ポンカン、レモン、ライムから選ばれる1種または2種以上のものと、根菜類に属するゴボウ、ニンジン、ニンニク、レンコン、ゆり根から選ばれる1種または2種以上のものと、穀類に属する玄米、もち米、白米、きび、とうもろこし、小麦、大麦、あわ、ひえから選ばれる1種または2種以上のものと、豆・ゴマ類に属する大豆、黒豆、黒ゴマ、白ゴマ、あずき、くるみから選ばれる1種または2種以上のものと、海草類に属するコンブ、ワカメ、ヒジキ、あおのり、かわのりから選ばれる1種または2種以上のものと、糖類に属する黒糖、果糖、ぶどう糖から選ばれる1種または2種以上のものと、はちみつ、澱粉、きゅうり、しそ、セロリ、桑、生姜から選ばれる1種または2種以上のものとを、発酵、熟成させることで得られるものである。発酵熟成期間は、3年3か月以上とした。また、発酵熟成過程においては、添加物、熱、水を人為的に加えず、且つ、3年以上静置での発酵とした。本実験では、各類から1種又は2種を選択して、15種類の原材料を選択して発酵させたもの(本発酵組成物)を用いた。
The present fermented composition (FBP) is a composition for producing one or more fruits selected from apple, persimmon, banana, pineapple, Akebia japonica, silver vine, fig, wild strawberry, strawberry, wild grape, grape, wild berry, peach, plum, blueberry, raspberry, and loquat; one or more citrus fruits selected from navel orange, hassaku citrus, Satsuma mandarin orange, summer mandarin orange, orange, Iyokan orange, kumquat, yuzu, kabosu, pomelo, ponkan, lemon, and lime; one or more root vegetables selected from burdock, carrot, garlic, lotus root, and lily root; and one or more grains selected from cereals. It is obtained by fermenting and maturing one or more kinds of grains selected from brown rice, glutinous rice, white rice, millet, corn, wheat, barley, foxtail millet, and barnyard millet, one or more kinds of grains selected from soybeans, black beans, black sesame seeds, white sesame seeds, adzuki beans, and walnuts, one or more kinds of grains selected from kelp, wakame, hijiki, green laver, and seaweed, one or more kinds of grains selected from brown sugar, fructose, and glucose, and one or more kinds of grains selected from honey, starch, cucumber, shiso, celery, mulberry, and ginger. The fermentation and maturation period was 3 years and 3 months or more. In addition, during the fermentation and maturation process, additives, heat, and water were not added artificially, and the fermentation was allowed to stand for 3 years or more. In this experiment, one or two types were selected from each category, and 15 types of raw materials were selected and fermented (the present fermented composition).
本実験で用いた導入豚は、23日齢ほ乳期子豚(交雑種)とした。試験設計は、抗生物質を含む一般的な飼料(対照区)および抗生物質をFBP(本発酵組成物)に置き換えた飼料(試験区)で飼育して比較した。対象区及び試験区ともに、同じ子豚用配合飼料を用いた。対象区には抗生物質としてアビラマイシンを40ppm加えて、試験区には抗生物質を添加しないものとした。反対に、試験区には本発酵組成物として0.125%を加えて、対照区には本発酵組成物を添加しないものとした。 The pigs used in this experiment were 23-day-old suckling piglets (crossbreed). The experiment was designed to compare feeding on a general feed containing antibiotics (control group) and a feed in which the antibiotics were replaced with FBP (the fermented composition) (test group). The same piglet compound feed was used in both the control and test groups. The control group received 40 ppm of avilamycin as an antibiotic, while the test group received no antibiotics. Conversely, the test group received 0.125% of the fermented composition, while the control group received no fermented composition.
本実験での摂食期間は、23日齢から50日齢とした。飼育環境は、単飼ケージとして、給餌方法は、自由飲水、及び不断給餌とした。子豚用配合飼料は、飼養段階に合わせた配合飼料を使用した。アビラマイシン(抗生物質)は、対照区では40ppm、試験区では0ppmとした。他方で、FBP(本発酵組成物)は、対照区では0%、試験区では0.125%とした。The feeding period in this experiment was from 23 to 50 days of age. The pigs were kept in single cages, with free access to water and constant feeding. Formulated feed for the piglets was used according to the breeding stage. Avilamycin (antibiotic) was 40 ppm in the control group and 0 ppm in the test group. On the other hand, FBP (the fermented composition) was 0% in the control group and 0.125% in the test group.
採材部位及び測定項目の組み合わせは、「ふん、糞便スコア・IgA」、「経静脈血、血液生化学分析」、「盲腸静脈血、短鎖脂肪酸分析」、「盲腸内容部物、短鎖脂肪酸分析」、「小腸・大腸、臓器測定・絨毛長・陰窩深さ」とした。The combinations of sampling sites and measurement items were as follows: "feces, fecal score/IgA," "venous blood, blood biochemistry analysis," "cecal venous blood, short-chain fatty acid analysis," "cecal contents, short-chain fatty acid analysis," and "small intestine/large intestine, organ measurements/villus length/crypt depth."
次に、糞便スコアを説明する。良好な便をコロコロ便としてスコア0とした。ソフトな便をスコア1として、下痢状の便をスコア2、水溶性の便をスコア3,より水溶性の程度の高い下痢をスコア4とした。スコアの数値が高くなると不良な便となる。 Next, the fecal score will be explained. Good stool was assigned a score of 0, with hard stools. Soft stools were assigned a score of 1, diarrhea-like stools a score of 2, water-soluble stools a score of 3, and diarrhea with a higher degree of water solubility a score of 4. The higher the score, the poorer the stool.
実験結果について説明する。図1(左)は、食用豚の成長成績を示すグラフである。まず、抗生物質を含む一般的な飼料(対照区)および抗生物質をFBP(本発酵組成物)に置き換えた飼料(試験区)で飼育した食用豚について、体重を測定してその推移をグラフにした。縦軸は重量(kg)、横軸は生後日齢(日)である。対照区及び試験区ともに、時間とともに同程度の体重増加が見られた。また、飼料要求率は、〔飼料摂取量(または消費量)(kg)/畜産物の生産量(kg)〕で算出され、図1(右)のグラフの縦軸は、kg/kgのため飼料要求率は無単位数である。 The experimental results will now be explained. Figure 1 (left) is a graph showing the growth performance of edible pigs. First, the weights of edible pigs raised on a general feed containing antibiotics (control group) and on a feed in which the antibiotics were replaced with FBP (the fermented composition) (test group) were measured and the changes in weight were graphed. The vertical axis is weight (kg) and the horizontal axis is age after birth (days). Both the control group and the test group showed a similar increase in weight over time. The feed conversion rate was calculated as [feed intake (or consumption) (kg) / livestock production (kg)], and the vertical axis of the graph in Figure 1 (right) is kg/kg, so the feed conversion rate is a unitless number.
次に、対照区及び試験区において、特定の時期における食用豚の飼料要求率を測定した(図1右)。生後日齢を重ねるごとに飼料要求率は高くなり、37日-44日の生後日齢でピークとなり、44日-55日の生後日齢で若干、飼料要求率は低くなる傾向にある。対照区及び試験区においても、飼料要求率はほぼ同じ数値を示した。なお、飼料要求率は、畜産物1kg当たりの生産に要する摂取(または消費)飼料数量のことで、増体など生産のために何倍の飼料を必要とするかを示し、飼料要求率が小さいほど効率が良いことを示すものである。Next, the feed conversion rate of the pigs for food was measured at specific times in the control and test groups (Figure 1, right). The feed conversion rate increases with increasing age, peaking at 37-44 days after birth and tending to decrease slightly at 44-55 days after birth. The feed conversion rate was almost the same in the control and test groups. The feed conversion rate is the amount of feed ingested (or consumed) required to produce 1 kg of livestock product, and indicates how many times the amount of feed is required for production, such as weight gain. The lower the feed conversion rate, the more efficient the efficiency.
図2は、対照区及び試験区において、特定の時期における腸内環境を観察したデータを示す。左グラフは、特定の日齢期間での糞便スコアを示す。糞便スコアの評価方法は、上述の通りである。対照区及び試験区ともに、糞便スコアは良好となり、期間中の腸内環境は安定していた。右グラフは、特定の日齢(23日、31日、50日)の糞便IgAスコアを示す。安静時における腸管免疫の変化は見られなかった。なお、糞便IgA濃度は腸管内の免疫状態と相関する。感染症などで糞便IgA濃度は高値を示し、逆に糞便IgA濃度が極端に低下すれば感染症リスクが高くなる。ここでは両群ともに低値で安定していたことから、腸内環境が比較的安定していたことを示すものと考えられる。 Figure 2 shows data on the intestinal environment at specific times in the control and test groups. The graph on the left shows the fecal scores at specific ages. The method for evaluating the fecal scores is as described above. In both the control and test groups, the fecal scores were good, and the intestinal environment was stable during the period. The graph on the right shows the fecal IgA scores at specific ages (23, 31, and 50 days). No changes in intestinal immunity were observed at rest. The fecal IgA concentration correlates with the immune state in the intestinal tract. Fecal IgA concentration shows high values due to infectious diseases, and conversely, if the fecal IgA concentration drops drastically, the risk of infectious diseases increases. Here, the low values were stable in both groups, which is thought to indicate that the intestinal environment was relatively stable.
図3は、対照区及び試験区において、盲腸内容物及び盲腸静脈血での短鎖脂肪酸濃度を示したグラフである。短鎖脂肪酸は、酢酸、プロピオン酸、n酪酸を測定した。盲腸内容物、静脈血ともに、対照区及び試験区の両群において、FBP給与で全体的な短鎖脂肪酸の構成比に大きな変動は見られなかったが、試験区においては短鎖脂肪酸濃度が高くなる傾向が認められた。 Figure 3 is a graph showing the concentration of short-chain fatty acids in the cecal contents and cecal venous blood in the control and test groups. The short-chain fatty acids measured were acetic acid, propionic acid, and n-butyric acid. In both the control and test groups, no significant change was observed in the overall composition ratio of short-chain fatty acids in the cecal contents and venous blood when FBP was fed, but a tendency for the short-chain fatty acid concentration to be higher was observed in the test group.
これらの短鎖脂肪酸を測定したのは、短鎖脂肪酸の有益性が注目されているからである。腸の粘膜は病原体の侵入を防ぐという腸管バリア機能を担っている。酪酸やプロピオン酸には、腸粘膜を維持して、腸のバリア機能を高める働きがある。特に、酪酸は腸上皮細胞の最も重要なエネルギー源であり、腸管上皮の新陳代謝を促進し、また、腸管の蠕動運動を促進すると報告されている。These short-chain fatty acids were measured because the benefits of short-chain fatty acids are attracting attention. The intestinal mucosa plays a role in the intestinal barrier function of preventing the invasion of pathogens. Butyric acid and propionic acid work to maintain the intestinal mucosa and enhance the intestinal barrier function. In particular, butyric acid is the most important energy source for intestinal epithelial cells, and has been reported to promote the metabolism of the intestinal epithelium and also promote intestinal peristalsis.
図4は、食用豚の消化管形状及び血液生化学検査を示す表である。対照区及び試験区において、小腸(長さ、重量)、大腸(長さ、重量)、消化吸収(絨毛高さ(μm)、陰窩深さ(μm) 、絨毛/陰窩深さ)といった解剖学的データ(消化管形状)については、両群において概ね差異がなかった。 Figure 4 is a table showing the digestive tract shape and blood biochemistry test results of the pigs. There were no major differences between the control and test groups in terms of anatomical data (digestive tract shape) such as the small intestine (length, weight), large intestine (length, weight), digestion and absorption (villus height (μm), crypt depth (μm), villi/crypt depth).
また、血液生化学検査でも、対照区及び試験区において、γ-GT、アルブミン、総コレステロール、尿素窒については、両群において概ね差異がなかった。これらの知見は、食用豚の成長成績を示すグラフ(図1)、食用豚の腸内環境(糞便スコア、糞便中IgA濃度)を評価するグラフ(図2)の結果と矛盾することなく、補強するものである。 Furthermore, blood biochemistry tests showed that there were no major differences between the control and test groups in terms of γ-GT, albumin, total cholesterol, and urea nitrogen. These findings do not contradict but support the results of the graph showing the growth performance of the edible pigs (Figure 1) and the graph evaluating the intestinal environment of the edible pigs (fecal score, fecal IgA concentration) (Figure 2).
図5は、本件発酵組成物の食用豚に与える効果機序の説明図である。食用豚の飼育において、生体に対するストレスや疾病によって、消化管内にいわゆる有害菌が増殖して、これらの有害菌が毒素や腐敗物を産出させて、消化管内部に損傷を与えることになる。具体的には、消化吸収機能を担う絨毛、陰窩の損傷を与えて結果として、下痢を引き起こすものとなる。 Figure 5 is an explanatory diagram of the mechanism of the effect of the present fermented composition on pigs for food. When raising pigs for food, so-called harmful bacteria grow in the digestive tract due to stress or illness on the living body, and these harmful bacteria produce toxins and putrefactive substances, causing damage to the inside of the digestive tract. Specifically, the villi and crypts, which are responsible for the digestive and absorptive functions, are damaged, resulting in diarrhea.
従来は、上記の対策として、家畜の飼育時に抗生物質を与えることで、消化管内のいわゆる有害菌を除去して、下痢などを防止して生育を図った。しかし、有害菌の中には、抗生物質に抵抗性のある菌が出現してしまうものがあった。 Traditionally, as a countermeasure to the above, livestock have been given antibiotics during breeding to eliminate harmful bacteria from the digestive tract and prevent diarrhea and other problems while promoting their growth. However, some harmful bacteria have developed resistance to antibiotics.
本発明に係る本件発酵組成物は、抗生物質を与えない場合も同様の効果が得られることから、家畜の飼育に用いられる抗生物質代替材とすることができた。すなわち、本件発酵組成物は、家畜の消化管内の有用菌を増加させて、この有用菌からの短鎖脂肪酸の生産を促し、栄養素利用推進され、良好な腸内環境を図ることができると考える。これは、抗生物質を与えない場合も同様の効果が得られることから、本発明に係る本件発酵組成物は、家畜の飼育に用いられる抗生物質代替材とすることができた。 The fermented composition of the present invention can provide the same effect even without antibiotics, making it an alternative to antibiotics for use in raising livestock. In other words, it is believed that the fermented composition of the present invention increases the number of useful bacteria in the digestive tract of livestock, promotes the production of short-chain fatty acids from these useful bacteria, and promotes nutrient utilization, resulting in a good intestinal environment. The fermented composition of the present invention can provide the same effect even without antibiotics, making it an alternative to antibiotics for use in raising livestock.
Claims (2)
主成分について、100g当たり、下記を含む、
水分:5.0g~50.0g、
タンパク質:0.5g~10.0g、
脂質:0.05g~10.00g、
炭水化物(糖質):30.0g~75.0g、
炭水化物(繊維):0.1g~5.0g、
灰分:0.5g~5.0g、
β-カロチン:10μg~150μg、
ビタミンA効力:10IU~100IU、
ビタミンB1:0.01mg~0.50mg、
ビタミンB2:0.01mg~0.50mg、
ビタミンB6:0.01mg~0.50mg、
ビタミンE:10.0mg以下、
ナイアシン:0.1mg~6.0mg、
カルシウム:50mg~900mg、
リン:200mg以下、
鉄:1.0mg~5.0mg、
ナトリウム:20mg~300mg、
カリウム:300mg~1000mg、
マグネシウム:40mg~200mg、
食塩相当量:0.05g~1.00g、
銅:7.0ppm以下、
アミノ酸組成について、100g中、
イソロイシン:30~200mg、
ロイシン:50~400mg、
リジン:20~200mg、
メチオニン:10~150mg、
シスチン:10~100mg、
フェニルアラニン:30~250mg、
チロシン:20~200mg、
スレオニン:40~200mg、
トリプトファン:1~100mg、
バリン:30~300mg、
ヒスチジン:10~200mg、
アルギニン:40~400mg、
アラニン:50~300mg、
アスパラキン酸:100~600mg、
グルタミン酸:100~1200mg、
グリシン:30~300mg、
プロリン:40~400mg、
セリン:30~300mg。
発酵組成物を主原料とする腸内で特定の短鎖脂肪酸を増加させる飼料用(家畜用)の植物発酵組成材を家畜に、畜肉の生産量1kg当たり1.56~2.25g給餌することによる家畜の飼育方法。 One or more kinds selected from apple, persimmon, banana, pineapple, Akebia japonica, silver vine, fig, wild strawberry, strawberry, wild grape, grape, wild berry, peach, plum, blueberry, raspberry, loquat belonging to the fruit category; one or more kinds selected from navel orange, hassaku citrus, Unshu mandarin orange, summer mandarin orange, orange, Iyokan, kumquat, yuzu, kabosu, pomelo, ponkan, lemon, lime belonging to the citrus category; one or more kinds selected from burdock, carrot, garlic, lotus root, lily root belonging to the root category; brown rice, glutinous rice, polished rice belonging to the grain category, The product is obtained by fermenting and maturing one or more kinds of grains selected from millet, corn, wheat, barley, foxtail millet, and barnyard millet, one or more kinds of grains selected from soybeans, black beans, black sesame seeds, white sesame seeds, adzuki beans, and walnuts, which belong to the beans and sesame family, one or more kinds of grains selected from kelp, wakame seaweed, hijiki seaweed, green laver seaweed, and seaweed, one or more kinds of grains selected from brown sugar, fructose, and glucose, which belong to the sugar family, and one or more kinds of grains selected from honey, starch, cucumber, shiso, celery, mulberry, and ginger, and has the following components and amino acid composition:
The main ingredients per 100g include:
Moisture: 5.0g to 50.0g,
Protein: 0.5g-10.0g,
Lipids: 0.05g to 10.00g,
Carbohydrates (sugar): 30.0g to 75.0g,
Carbohydrates (fiber): 0.1g-5.0g,
Ash content: 0.5g to 5.0g,
β-carotene: 10 μg to 150 μg,
Vitamin A potency: 10 IU to 100 IU,
Vitamin B1 : 0.01 mg to 0.50 mg,
Vitamin B2 : 0.01 mg to 0.50 mg,
Vitamin B6 : 0.01 mg to 0.50 mg,
Vitamin E: 10.0 mg or less,
Niacin: 0.1 mg to 6.0 mg,
Calcium: 50mg to 900mg,
Phosphorus: 200 mg or less,
Iron: 1.0 mg to 5.0 mg,
Sodium: 20mg to 300mg,
Potassium: 300mg to 1000mg,
Magnesium: 40mg to 200mg,
Salt equivalent: 0.05g to 1.00g,
Copper: 7.0 ppm or less,
Amino acid composition per 100g:
Isoleucine: 30-200 mg,
Leucine: 50-400 mg,
Lysine: 20-200 mg,
Methionine: 10-150 mg,
Cystine: 10-100 mg,
Phenylalanine: 30-250 mg,
Tyrosine: 20-200 mg,
Threonine: 40-200 mg,
Tryptophan: 1-100 mg,
Valine: 30-300 mg,
Histidine: 10-200 mg,
Arginine: 40-400 mg,
Alanine: 50-300 mg,
Aspartic acid: 100-600 mg,
Glutamic acid: 100-1200 mg,
Glycine: 30-300 mg,
Proline: 40-400 mg,
Serine: 30-300 mg.
A method for raising livestock, comprising feeding 1.56 to 2.25 g of a fermented plant composition for livestock feed, which contains a fermented composition as a main ingredient and increases specific short-chain fatty acids in the intestines, to the livestock per kg of meat production .
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021211087 | 2021-12-24 | ||
| JP2021211087 | 2021-12-24 | ||
| PCT/JP2022/038769 WO2023119820A1 (en) | 2021-12-24 | 2022-10-18 | Fermented composition for feed, and method for raising livestock |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2023119820A1 JPWO2023119820A1 (en) | 2023-06-29 |
| JP7616722B2 true JP7616722B2 (en) | 2025-01-17 |
Family
ID=86901983
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023569093A Active JP7616722B2 (en) | 2021-12-24 | 2022-10-18 | How to raise livestock |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JP7616722B2 (en) |
| WO (1) | WO2023119820A1 (en) |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001269125A (en) | 2000-03-29 | 2001-10-02 | Nihon Nosan Kogyo Kk | Feed for pig |
| JP2003238400A (en) | 2002-02-12 | 2003-08-27 | Nippon Zenyaku Kogyo Kk | Anticoccidial composition and fodder containing the same |
| JP2005065671A (en) | 2003-08-26 | 2005-03-17 | Gouda:Kk | Fermented feed |
| JP2007084504A (en) | 2005-09-26 | 2007-04-05 | Sanwa Shiyurui Kk | A composition having an angiogenesis-inhibiting action, comprising as an active ingredient barley fermented |
| JP2014011994A (en) | 2012-06-07 | 2014-01-23 | Takara Bio Inc | Composition containing basidiomycete which is cultured on culture medium containing brewing lees |
| WO2015197623A1 (en) | 2014-06-26 | 2015-12-30 | Novozymes A/S | Improved protein bio-availability of palm kernel cake using milder expeller conditions and enzymatic treatment |
| JP2019182763A (en) | 2018-04-05 | 2019-10-24 | 株式会社ダイワ | Composition, and food and feed containing the same |
| JP2020043838A (en) | 2018-09-21 | 2020-03-26 | 天草梅肉ポーク株式会社 | Livestock feed additive and method for producing the same |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0787899A (en) * | 1993-09-22 | 1995-04-04 | Hokueiken Corp:Kk | Additive for hog-raising feed |
| MY128092A (en) * | 1996-07-10 | 2007-01-31 | Manda Fermentation Co Ltd | Fermented composition, method for manufacturing same, and applications thereof |
-
2022
- 2022-10-18 JP JP2023569093A patent/JP7616722B2/en active Active
- 2022-10-18 WO PCT/JP2022/038769 patent/WO2023119820A1/en not_active Ceased
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001269125A (en) | 2000-03-29 | 2001-10-02 | Nihon Nosan Kogyo Kk | Feed for pig |
| JP2003238400A (en) | 2002-02-12 | 2003-08-27 | Nippon Zenyaku Kogyo Kk | Anticoccidial composition and fodder containing the same |
| JP2005065671A (en) | 2003-08-26 | 2005-03-17 | Gouda:Kk | Fermented feed |
| JP2007084504A (en) | 2005-09-26 | 2007-04-05 | Sanwa Shiyurui Kk | A composition having an angiogenesis-inhibiting action, comprising as an active ingredient barley fermented |
| JP2014011994A (en) | 2012-06-07 | 2014-01-23 | Takara Bio Inc | Composition containing basidiomycete which is cultured on culture medium containing brewing lees |
| WO2015197623A1 (en) | 2014-06-26 | 2015-12-30 | Novozymes A/S | Improved protein bio-availability of palm kernel cake using milder expeller conditions and enzymatic treatment |
| JP2019182763A (en) | 2018-04-05 | 2019-10-24 | 株式会社ダイワ | Composition, and food and feed containing the same |
| JP2020043838A (en) | 2018-09-21 | 2020-03-26 | 天草梅肉ポーク株式会社 | Livestock feed additive and method for producing the same |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2023119820A1 (en) | 2023-06-29 |
| JPWO2023119820A1 (en) | 2023-06-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Saliu et al. | Dietary fiber and its role in performance, welfare, and health of pigs | |
| Tan et al. | Effects of dietary chlorogenic acid on intestinal barrier function and the inflammatory response in broilers during lipopolysaccharide-induced immune stress | |
| Donma et al. | Beneficial effects of poultry meat consumption on cardiovascular health and the prevention of childhood obesity | |
| Laitat et al. | Influence of sugar beet pulp on feeding behavior, growth performance, carcass quality and gut health of fattening pigs. | |
| CN105029127A (en) | Broiler chicken starter feed | |
| Baurhoo et al. | Comparison of corn-based and Canadian pearl millet-based diets on performance, digestibility, villus morphology, and digestive microbial populations in broiler chickens | |
| CN110786424A (en) | Application of magnolol and/or honokiol in poultry breeding | |
| RU2470522C2 (en) | Impact on pigs for fodder assimilation coefficient reduction or growth rate increase | |
| Elbaz | Effect of Linseed Oil and Fermented Pomegranate Peel supplementation on the growth performance, Digestive function, and muscle fatty acid deposition of heat-stress broiler chickens | |
| CN110916004A (en) | Weaning-resistant stress piglet creep feed and preparation method and application thereof | |
| JP2009531030A (en) | Treatment of poultry to reduce feed conversion or to reduce the incidence of ascites | |
| BR112018012720B1 (en) | INGREDIENT FOR ANIMAL NUTRITION | |
| JP7616722B2 (en) | How to raise livestock | |
| JP6092899B2 (en) | Methods for improving animal feed efficiency and carcass characteristics | |
| Kumar et al. | Effect of live Saccharomyces cerevisiae feeding on serum biochemistry in early weaned cross bred piglets | |
| WO2020149859A1 (en) | Use of zinc butyrate and chromium propionate for the treatment and prevention of woody breast disease in broilers | |
| US20250099529A1 (en) | Composition for improving immunity of companion animals | |
| CN119404958A (en) | A feed additive and its application | |
| CN113728949B (en) | Method for preventing and controlling rotten body disease of herbivorous fishes and omnivorous fishes | |
| CN112617023B (en) | Composition containing feather protein powder and preparation method thereof | |
| CN107668348A (en) | A kind of compound additive for improving intestine of young pigs health and preparation method and application | |
| Troya et al. | Comparison of the colic incidence in a horse population with or without inclusion of germinated barley in the diet | |
| CN113678762A (en) | Prevention and control method for skin rot of carnivorous fish | |
| Amaefule et al. | Performance, nutrient utilization and intestinal environment of weaned rabbits fed diets supplemented with organic acids in the humid tropics | |
| KR102687197B1 (en) | Feed additives for livestock and poultry that exhibit immunity-boosting effects and methods for producing antibiotic-free meat using the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20240517 |
|
| A80 | Written request to apply exceptions to lack of novelty of invention |
Free format text: JAPANESE INTERMEDIATE CODE: A801 Effective date: 20240517 |
|
| A871 | Explanation of circumstances concerning accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A871 Effective date: 20240517 |
|
| A80 | Written request to apply exceptions to lack of novelty of invention |
Free format text: JAPANESE INTERMEDIATE CODE: A80 Effective date: 20240517 |
|
| AA64 | Notification of invalidation of claim of internal priority (with term) |
Free format text: JAPANESE INTERMEDIATE CODE: A241764 Effective date: 20240625 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240801 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20240917 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20241108 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20241203 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20241223 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7616722 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |